Parkman Healthcare Partners LLC Mannkind Corp Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Mannkind Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 3,304,085 shares of MNKD stock, worth $23.2 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares

3,304,085

Previous 2,409,599 37.12%

Holding current value

$23.2 Million

Previous $12.6 Million 64.96%

% of portfolio

2.93%

Previous 1.86%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $4.48 Million - $5.99 Million	894,486 Added 37.12%	3,304,085 $20.7 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $5.43 $14,835 - $19,890	3,663 Added 0.15%	2,409,599 $12.6 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $301,236 - $488,465	-92,688 Reduced 3.71%	2,405,936 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $1.44 Million - $1.84 Million	429,677 Added 20.77%	2,498,624 $9.09 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $986,751 - $1.38 Million	252,366 Added 13.89%	2,068,947 $8.54 Million
Q2 2023 Aug 11, 2023	BUY	$3.72 - $4.79 $1.27 Million - $1.64 Million	342,483 Added 23.23%	1,816,581 $7.39 Million
Q1 2023 May 12, 2023	BUY	$3.95 - $5.63 $1.75 Million - $2.49 Million	442,989 Added 42.96%	1,474,098 $6.04 Million
Q4 2022 Feb 13, 2023	BUY	$3.02 - $5.37 $320,512 - $569,918	106,130 Added 11.47%	1,031,109 $5.43 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $478,893 - $696,717	160,165 Added 20.94%	924,979 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $238,727 - $426,490	89,411 Added 13.24%	764,814 $2.91 Million
Q1 2022 May 13, 2022	BUY	$2.62 - $4.45 $1.07 Million - $1.82 Million	409,548 Added 154.05%	675,403 $2.49 Million
Q4 2021 Feb 11, 2022	BUY	$4.05 - $5.37 $43,772 - $58,038	10,808 Added 4.24%	265,855 $1.16 Million
Q3 2021 Nov 12, 2021	SELL	$3.89 - $5.48 $2.14 Million - $3.01 Million	-550,000 Reduced 68.32%	255,047 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.45 $1.46 Million - $2.21 Million	405,047 Added 101.26%	805,047 $4.39 Million
Q1 2021 May 14, 2021	BUY	$3.14 - $6.14 $1.26 Million - $2.46 Million	400,000 New	400,000 $1.57 Million
Q4 2020 Feb 12, 2021	SELL	$1.79 - $4.04 $628,701 - $1.42 Million	-351,230 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $311,823 - $415,764	-199,887 Reduced 36.27%	351,230 $660,000
Q2 2020 Aug 13, 2020	SELL	$0.94 - $2.21 $329,000 - $773,500	-350,000 Reduced 38.84%	551,117 $964,000
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $440,315 - $922,565	-524,185 Reduced 36.78%	901,117 $928,000
Q4 2019 Feb 13, 2020	BUY	$1.14 - $1.49 $1.62 Million - $2.12 Million	1,425,302 New	1,425,302 $1.84 Million

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Mannkind Corp Transaction History